Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc. (NHS)

The most critical issue here is the massive payout ratio of 181%, which indicates the fund is distributing nearly double its earnings. While the headline yield of 17.5% looks attractive, this is unsustainable capital extraction rather than a reliable income stream, capping the dividend rating at a low level. Fundamentally, the business is struggling; despite a recent quarterly earnings bump, the broader trend shows negative earnings growth and a significant drag on the share price, which has lost over 30% of its value over the last nine years. The recent announcement of a rights offering suggests management is actively trying to raise capital, often a sign of distress or dilution risk for existing holders. With the stock trading below book value but showing no clear path to reversing its multi-year decline, the long-term outlook remains weak. Short-term, the price is hovering near its 52-week lows with no immediate catalyst for a rebound, leaving it in a neutral zone where neither a buy nor a sell is strongly indicated by the current data.